Global Blood Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Feb 14, 2023 08:34 ET
Global Blood Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.410%),Abigail P. Johnson(0.410%)
Feb 9, 2023 10:59 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:21 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:20 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 6, 2022 16:15 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Oct 4, 2022 17:00 ET
Global Blood Therapeutics | 4: Statement of changes in beneficial ownership of securities
Sep 29, 2022 20:48 ET
No Data
No Data